VERIMMUNE
ABOUT US Technology
News Contact
ABOUT USTechnology
VERIMMUNE
PIONEERING ANTI-TUMOR IMMUNE REDIRECTION
NewsContact
VerImmune Receives SBIR Phase II Award from the National Science Foundation
VerImmune Receives SBIR Phase II Award from the National Science Foundation

VerImmune Receives SBIR Phase II Award from the National Science Foundation

Read More
joshua wangSeptember 2, 2020
VerImmune Announces New Board, Advisors and Officers
VerImmune Announces New Board, Advisors and Officers
Michaela FlatleyJanuary 13, 2020
VerImmune to Present at Biotech Showcase™ 2020 in San Francisco
VerImmune to Present at Biotech Showcase™ 2020 in San Francisco
Michaela FlatleyJanuary 10, 2020
Newer

Learn more.

CONTACT US
LINKEDINTWITTERFacebook